References
- Bauer J H, Brooks C S. The long-term effect of propranolol therapy on renal function. Am J Med 1979; 66: 405–10
- Ibsen H, Sederberg-Olsen P. Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin Sci 1973; 44: 129–34
- Wilkinson R. β-Blockers and renal function. Drμgs 1982; 23: 195–206
- Brøchner-Mortensen J, Jensen S, Rødbro P. Delimitation of plasma creatinine concentration values for assessment of relative renal function in adult patients. Scand J Urol Nephrol 1977; 11: 257–62
- Brøchner-Mortensen J. A simple method for determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271–4
- Brøchner-Mortensen J, Rødbro P. Comparison between total and renal plasma clearance of 51Cr-EDTA. Scand J Clin Lab Invest 1976; 36: 247–9
- Brøchner-Mortensen J, Rødbro P. Optimum time of blood sampling for determination of glomerular filtration rate by single injection 51Cr-EDTA plasma clearance. Scand J Clin Lab Invest 1976; 36: 795–800
- Brøchner-Mortensen J. A simple single injection method for determination of the extracellular fluid volume. Scand J Clin Lab Invest 1980; 40: 567–73
- Tauxe W N, Maher F T, Taylor W M. Effective renal plasma flow: estimation from theoretical volumes of distribution of intravenously injected 131-I-orthoiodohippurate. Mayo Clin Proc 1971; 46: 524–31
- Moses L E. Confidence limits from rank tests (Query 10). Technometrics 1965; 7: 257–60
- Warren D J, Swainson C P, Wright N. Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension. Br Med J 1974; 2: 193–4
- Snell A, Wallace M. Beta-blockade in the presence of renal disease and hypertension. Br Med J 1974; 2: 672
- Kincaid-Smith P, Hua A SP. Beta-adrenergic blocking agents in renal failure. Br Med J 1974; 3: 520
- Thompson F D, Joekes A M. Beta-blockade in the presence of renal disease and hypertension. Br Med J 1974; 2: 555–6
- Falch D K, Ødegaard A E, Norman N. Decreased renal plasma flow during propranolol treatment in essential hypertension. Acta Med Scand 1979; 205: 91–5
- Falch D K, Ødegaard A E, Norman N. Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension. Scand J Clin Lab Invest 1978; 38: 143–6
- Pedersen E B, Larsen J S. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension. Postgrad Med J 1980; 56(Suppl. 2)27–32
- Malini R L, Strocchi E, Negroni S, Ambrosioni E, Magnani B. Renal haemodynamics after chronic treatment with labetalol and propranolol. Br J Clin Pharmac 1982; 13(Suppl. 1)123 S–126 S
- Sederberg-Olsen P, Ibsen H. Plasma volume and extracellular fluid volume during long-term treatment with propranolol in essential hypertension. Clin Sci 1972; 43: 165–70